miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome

Bleeding is a major adverse event during clopidogrel treatment in patients with acute coronary syndrome (ACS). However, the potential mechanism affecting bleeding among individuals is unclear. Herein, we investigated the involvement of CYP2C19*2 and CYP2C19*3, as well as 10 miRNA polymorphisms, in b...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Zhen-Zhen, Yuan, Zhen, Peng, Yuan-Yuan, Zhou, Wan-Lu, Dai, Wei, Wang, Guo, Tang, Jie, Zhang, Wei, Chen, Bi-Lian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951409/
https://www.ncbi.nlm.nih.gov/pubmed/36829258
http://dx.doi.org/10.1186/s40001-023-01068-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951409/
https://www.ncbi.nlm.nih.gov/pubmed/36829258
http://dx.doi.org/10.1186/s40001-023-01068-9

Ejemplares similares